Implement an automatic aerosol production process compliant with the ATEX 2014-34-EU Directive, based on the index line with indexing propulsion. (Q123137): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): The project consists of implementing an innovative production process for aerosol products compliant with the ATEX Directive 2014-34-EU, on the basis of the index-based technology. The investment will enable the Applicant to enter the medical devices market with high technological and qualitative requirements. As a result of a fundamental change in the production process a range of innovative products (including those resulting from the R & D)...) |
(Created claim: summary (P836): The project consists of implementing an innovative production process for aerosol products in accordance with the ATEX 2014-34-EU Directive, based on a technological line with index drive. The investment is intended to enable the Applicant to enter the market of medical devices, characterised by high technological requirements and a quality regime. The fundamental change in the production process will result in the development of a range of inno...) |
||||||||||||||
| Property / summary | |||||||||||||||
The project consists of implementing an innovative production process for aerosol products in accordance with the ATEX 2014-34-EU Directive, based on a technological line with index drive. The investment is intended to enable the Applicant to enter the market of medical devices, characterised by high technological requirements and a quality regime. The fundamental change in the production process will result in the development of a range of innovative products (including those resulting from R & D) requiring a certificate of medical device. The investment will allow obtaining such a certificate (TUV), which will significantly improve the position of the company and allow it to compete with foreign producers. Energy efficiency, recuperation, use of RES and the implementation of lean manufacturing for new production will help reduce its negative impact on the environment. The potential for further technological development of the Applicant and the implementation of further innovations will significantly increase. The project will create eight new jobs. (English) | |||||||||||||||
| Property / summary: The project consists of implementing an innovative production process for aerosol products in accordance with the ATEX 2014-34-EU Directive, based on a technological line with index drive. The investment is intended to enable the Applicant to enter the market of medical devices, characterised by high technological requirements and a quality regime. The fundamental change in the production process will result in the development of a range of innovative products (including those resulting from R & D) requiring a certificate of medical device. The investment will allow obtaining such a certificate (TUV), which will significantly improve the position of the company and allow it to compete with foreign producers. Energy efficiency, recuperation, use of RES and the implementation of lean manufacturing for new production will help reduce its negative impact on the environment. The potential for further technological development of the Applicant and the implementation of further innovations will significantly increase. The project will create eight new jobs. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The project consists of implementing an innovative production process for aerosol products in accordance with the ATEX 2014-34-EU Directive, based on a technological line with index drive. The investment is intended to enable the Applicant to enter the market of medical devices, characterised by high technological requirements and a quality regime. The fundamental change in the production process will result in the development of a range of innovative products (including those resulting from R & D) requiring a certificate of medical device. The investment will allow obtaining such a certificate (TUV), which will significantly improve the position of the company and allow it to compete with foreign producers. Energy efficiency, recuperation, use of RES and the implementation of lean manufacturing for new production will help reduce its negative impact on the environment. The potential for further technological development of the Applicant and the implementation of further innovations will significantly increase. The project will create eight new jobs. (English) / qualifier | |||||||||||||||
point in time: 21 October 2020
| |||||||||||||||
Revision as of 10:52, 21 October 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Implement an automatic aerosol production process compliant with the ATEX 2014-34-EU Directive, based on the index line with indexing propulsion. |
Project in Poland financed by DG Regio |
Statements
975,575.0 zloty
0 references
2,786,950.5 zloty
0 references
35.01 percent
0 references
1 October 2018
0 references
30 September 2020
0 references
"WATS" PIASECKI I WSPÓLNICY SPÓŁKA JAWNA
0 references
50°12'34.6"N, 19°7'58.1"E
0 references
Przedsięwzięcie polega na wdrożeniu innowacyjnego procesu produkcji wyrobów aerozolowych zgodnego z dyrektywą ATEX 2014-34-EU, w oparciu o linię technologiczną z napędem indeksującym. Inwestycja ma umożliwić Wnioskodawcy wejście na rynek wyrobów medycznych, cechujący się wysokimi wymogami technologicznymi i reżimem jakościowym. W wyniku zasadniczej zmiany procesu produkcyjnego nastąpi rozwój gamy innowacyjnych produktów (w tym powstałych w wyniku prac B+R), wymagających certyfikatu wyrobu medycznego. Inwestycja umożliwi zdobycie takiego certyfikatu (TUV), co znacząco poprawi pozycję przedsiębiorstwa i pozwoli mu na konkurowanie z zagranicznymi producentami. Energooszczędność, rekuperacja, wykorzystanie OZE i wdrożenie lean manufacturing do nowej produkcji, sprzyjać będą ograniczaniu jej negatywnego wpływu na środowisko. Istotnie zwiększy się możliwość dalszego rozwoju technologicznego Wnioskodawcy i wdrażania kolejnych innowacji. Projekt umożliwi stworzenie ośmiu nowych miejsc pracy. (Polish)
0 references
The project consists of implementing an innovative production process for aerosol products in accordance with the ATEX 2014-34-EU Directive, based on a technological line with index drive. The investment is intended to enable the Applicant to enter the market of medical devices, characterised by high technological requirements and a quality regime. The fundamental change in the production process will result in the development of a range of innovative products (including those resulting from R & D) requiring a certificate of medical device. The investment will allow obtaining such a certificate (TUV), which will significantly improve the position of the company and allow it to compete with foreign producers. Energy efficiency, recuperation, use of RES and the implementation of lean manufacturing for new production will help reduce its negative impact on the environment. The potential for further technological development of the Applicant and the implementation of further innovations will significantly increase. The project will create eight new jobs. (English)
21 October 2020
0 references
Identifiers
RPSL.03.02.00-24-0141/18
0 references